The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Varicella-Zoster Immunoglobulin Market Research Report 2025

Global Human Varicella-Zoster Immunoglobulin Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1737065

No of Pages : 87

Ask Your Query

Synopsis
Human varicella-zoster immune globulin is a solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.

Global Human Varicella-Zoster Immunoglobulin market is projected to reach US$ 201.1 million in 2029, increasing from US$ 159 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Varicella-Zoster Immunoglobulin market research.

Herpes zoster is an acute herpetic viral skin disease caused by the varicella-zoster virus that involves the nerves and skin. Infected individuals treated with human water were less likely to develop severe varicella-zoster virus than those not treated with it.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Varicella-Zoster Immunoglobulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Bio Products Laboratory
  • MassBiologics
  • Saol Therapeutics
  • Aptevo Biotherapeutics Llc
  • Ki Biopharma Llc
  • Cangene Biopharma
  • Kamada
  • Salmedon

Segment by Type

  • Freeze-dried Powder
  • Injection

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Human Varicella-Zoster Immunoglobulin report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Human Varicella-Zoster Immunoglobulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Varicella-Zoster Immunoglobulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Varicella-Zoster Immunoglobulin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Varicella-Zoster Immunoglobulin Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Varicella-Zoster Immunoglobulin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Varicella-Zoster Immunoglobulin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Varicella-Zoster Immunoglobulin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Varicella-Zoster Immunoglobulin Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Varicella-Zoster Immunoglobulin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Varicella-Zoster Immunoglobulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Varicella-Zoster Immunoglobulin, Product Type & Application
Table 12. Global Key Manufacturers of Human Varicella-Zoster Immunoglobulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Varicella-Zoster Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Varicella-Zoster Immunoglobulin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Varicella-Zoster Immunoglobulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Varicella-Zoster Immunoglobulin Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Varicella-Zoster Immunoglobulin Sales Market Share by Region (2018-2023)
Table 19. Global Human Varicella-Zoster Immunoglobulin Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Varicella-Zoster Immunoglobulin Sales Market Share by Region (2024-2029)
Table 21. Global Human Varicella-Zoster Immunoglobulin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Region (2018-2023)
Table 23. Global Human Varicella-Zoster Immunoglobulin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Region (2024-2029)
Table 25. North America Human Varicella-Zoster Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Varicella-Zoster Immunoglobulin Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Varicella-Zoster Immunoglobulin Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Varicella-Zoster Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Varicella-Zoster Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Varicella-Zoster Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Varicella-Zoster Immunoglobulin Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Varicella-Zoster Immunoglobulin Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Varicella-Zoster Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Varicella-Zoster Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Varicella-Zoster Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Varicella-Zoster Immunoglobulin Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Varicella-Zoster Immunoglobulin Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Varicella-Zoster Immunoglobulin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Varicella-Zoster Immunoglobulin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Varicella-Zoster Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Varicella-Zoster Immunoglobulin Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Varicella-Zoster Immunoglobulin Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Varicella-Zoster Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Varicella-Zoster Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Varicella-Zoster Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Varicella-Zoster Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Varicella-Zoster Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Varicella-Zoster Immunoglobulin Sales (K Units) by Type (2018-2023)
Table 51. Global Human Varicella-Zoster Immunoglobulin Sales (K Units) by Type (2024-2029)
Table 52. Global Human Varicella-Zoster Immunoglobulin Sales Market Share by Type (2018-2023)
Table 53. Global Human Varicella-Zoster Immunoglobulin Sales Market Share by Type (2024-2029)
Table 54. Global Human Varicella-Zoster Immunoglobulin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Varicella-Zoster Immunoglobulin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Type (2018-2023)
Table 57. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Type (2024-2029)
Table 58. Global Human Varicella-Zoster Immunoglobulin Price (US$/Unit) by Type (2018-2023)
Table 59. Global Human Varicella-Zoster Immunoglobulin Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Varicella-Zoster Immunoglobulin Sales (K Units) by Application (2018-2023)
Table 61. Global Human Varicella-Zoster Immunoglobulin Sales (K Units) by Application (2024-2029)
Table 62. Global Human Varicella-Zoster Immunoglobulin Sales Market Share by Application (2018-2023)
Table 63. Global Human Varicella-Zoster Immunoglobulin Sales Market Share by Application (2024-2029)
Table 64. Global Human Varicella-Zoster Immunoglobulin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Varicella-Zoster Immunoglobulin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Application (2018-2023)
Table 67. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Application (2024-2029)
Table 68. Global Human Varicella-Zoster Immunoglobulin Price (US$/Unit) by Application (2018-2023)
Table 69. Global Human Varicella-Zoster Immunoglobulin Price (US$/Unit) by Application (2024-2029)
Table 70. Bio Products Laboratory Corporation Information
Table 71. Bio Products Laboratory Description and Business Overview
Table 72. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product
Table 74. Bio Products Laboratory Recent Developments/Updates
Table 75. MassBiologics Corporation Information
Table 76. MassBiologics Description and Business Overview
Table 77. MassBiologics Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. MassBiologics Human Varicella-Zoster Immunoglobulin Product
Table 79. MassBiologics Recent Developments/Updates
Table 80. Saol Therapeutics Corporation Information
Table 81. Saol Therapeutics Description and Business Overview
Table 82. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product
Table 84. Saol Therapeutics Recent Developments/Updates
Table 85. Aptevo Biotherapeutics Llc Corporation Information
Table 86. Aptevo Biotherapeutics Llc Description and Business Overview
Table 87. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product
Table 89. Aptevo Biotherapeutics Llc Recent Developments/Updates
Table 90. Ki Biopharma Llc Corporation Information
Table 91. Ki Biopharma Llc Description and Business Overview
Table 92. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product
Table 94. Ki Biopharma Llc Recent Developments/Updates
Table 95. Cangene Biopharma Corporation Information
Table 96. Cangene Biopharma Description and Business Overview
Table 97. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product
Table 99. Cangene Biopharma Recent Developments/Updates
Table 100. Kamada Corporation Information
Table 101. Kamada Description and Business Overview
Table 102. Kamada Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Kamada Human Varicella-Zoster Immunoglobulin Product
Table 104. Kamada Recent Developments/Updates
Table 105. Salmedon Corporation Information
Table 106. Salmedon Description and Business Overview
Table 107. Salmedon Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Salmedon Human Varicella-Zoster Immunoglobulin Product
Table 109. Salmedon Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Human Varicella-Zoster Immunoglobulin Distributors List
Table 113. Human Varicella-Zoster Immunoglobulin Customers List
Table 114. Human Varicella-Zoster Immunoglobulin Market Trends
Table 115. Human Varicella-Zoster Immunoglobulin Market Drivers
Table 116. Human Varicella-Zoster Immunoglobulin Market Challenges
Table 117. Human Varicella-Zoster Immunoglobulin Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Varicella-Zoster Immunoglobulin
Figure 2. Global Human Varicella-Zoster Immunoglobulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Varicella-Zoster Immunoglobulin Market Share by Type in 2022 & 2029
Figure 4. Freeze-dried Powder Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Human Varicella-Zoster Immunoglobulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Varicella-Zoster Immunoglobulin Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Human Varicella-Zoster Immunoglobulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Human Varicella-Zoster Immunoglobulin Market Size (2018-2029) & (US$ Million)
Figure 12. Global Human Varicella-Zoster Immunoglobulin Sales (2018-2029) & (K Units)
Figure 13. Global Human Varicella-Zoster Immunoglobulin Average Price (US$/Unit) & (2018-2029)
Figure 14. Human Varicella-Zoster Immunoglobulin Report Years Considered
Figure 15. Human Varicella-Zoster Immunoglobulin Sales Share by Manufacturers in 2022
Figure 16. Global Human Varicella-Zoster Immunoglobulin Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Human Varicella-Zoster Immunoglobulin Players: Market Share by Revenue in 2022
Figure 18. Human Varicella-Zoster Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Human Varicella-Zoster Immunoglobulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2018-2029)
Figure 21. North America Human Varicella-Zoster Immunoglobulin Revenue Market Share by Country (2018-2029)
Figure 22. United States Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2018-2029)
Figure 25. Europe Human Varicella-Zoster Immunoglobulin Revenue Market Share by Country (2018-2029)
Figure 26. Germany Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Human Varicella-Zoster Immunoglobulin Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Human Varicella-Zoster Immunoglobulin Revenue Market Share by Region (2018-2029)
Figure 33. China Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2018-2029)
Figure 41. Latin America Human Varicella-Zoster Immunoglobulin Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Colombia Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Human Varicella-Zoster Immunoglobulin Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Human Varicella-Zoster Immunoglobulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Human Varicella-Zoster Immunoglobulin by Type (2018-2029)
Figure 52. Global Revenue Market Share of Human Varicella-Zoster Immunoglobulin by Type (2018-2029)
Figure 53. Global Human Varicella-Zoster Immunoglobulin Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Human Varicella-Zoster Immunoglobulin by Application (2018-2029)
Figure 55. Global Revenue Market Share of Human Varicella-Zoster Immunoglobulin by Application (2018-2029)
Figure 56. Global Human Varicella-Zoster Immunoglobulin Price (US$/Unit) by Application (2018-2029)
Figure 57. Human Varicella-Zoster Immunoglobulin Value Chain
Figure 58. Human Varicella-Zoster Immunoglobulin Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock